캐나다 -
영어 -
Health Canada
jinarc tablet
otsuka pharmaceutical co ltd - tolvaptan; tolvaptan - tablet - 45mg; 15mg - tolvaptan 45mg; tolvaptan 15mg - vasopressin antagonists
캐나다 -
영어 -
Health Canada
jinarc tablet
otsuka pharmaceutical co ltd - tolvaptan; tolvaptan - tablet - 60mg; 30mg - tolvaptan 60mg; tolvaptan 30mg - vasopressin antagonists
캐나다 -
영어 -
Health Canada
jinarc tablet
otsuka pharmaceutical co ltd - tolvaptan; tolvaptan - tablet - 90mg; 30mg - tolvaptan 90mg; tolvaptan 30mg - vasopressin antagonists
캐나다 -
영어 -
Health Canada
jinarc tablet
otsuka pharmaceutical co ltd - tolvaptan; tolvaptan - tablet - 15mg; 15mg - tolvaptan 15mg; tolvaptan 15mg - vasopressin antagonists
캐나다 -
영어 -
Health Canada
jinarc tablet
otsuka pharmaceutical co ltd - tolvaptan; tolvaptan - tablet - 30mg; 15mg - tolvaptan 30mg; tolvaptan 15mg - vasopressin antagonists
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
jinarc 15mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 15mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
samsca 30mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 30mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
samsca 15mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 15mg
뉴질랜드 -
영어 -
Medsafe (Medicines Safety Authority)
jinarc
pharmacy retailing (nz) ltd t/a healthcare logistics - tolvaptan 15mg; ; tolvaptan 45mg - combination - active: tolvaptan 15mg excipient: hyprolose indigo carmine aluminium lake lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: tolvaptan 45mg excipient: hyprolose indigo carmine aluminium lake lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - jinarc is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (adpkd) in adults with chronic kidney disease (ckd) stage 1 to 4 at initiation of treatment with evidence of rapidly progressing disease.
뉴질랜드 -
영어 -
Medsafe (Medicines Safety Authority)
jinarc
pharmacy retailing (nz) ltd t/a healthcare logistics - tolvaptan 30mg; ; tolvaptan 60mg - combination - active: tolvaptan 30mg excipient: hyprolose indigo carmine aluminium lake lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: tolvaptan 60mg excipient: hyprolose indigo carmine aluminium lake lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - jinarc is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (adpkd) in adults with chronic kidney disease (ckd) stage 1 to 4 at initiation of treatment with evidence of rapidly progressing disease.